Clinical Trial Update: Study of Paclitaxel, Carboplatin, and PF-05212384 in Advanced or Metastatic NSCLC (UF-STO-LUNG-002) [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating paclitaxel, carboplatin, and PF-05212384 in advanced or metastatic non-small cell lung cancer has been terminated with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• PF-05212384

Snippet

Sponsor: University of Florida | Conditions: Non-Small Cell Lung Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2019-10-03